{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:45:50Z","timestamp":1781736350968,"version":"3.54.5"},"reference-count":115,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HG010863"],"award-info":[{"award-number":["R01HG010863"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI152183"],"award-info":[{"award-number":["R01AI152183"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI154659"],"award-info":[{"award-number":["U01AI154659"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jaip.2024.05.003","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T03:29:32Z","timestamp":1715311772000},"page":"2599-2609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Improving Clinical Practice Through Patient Registries in Allergy and Immunology"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3446-9259","authenticated-orcid":false,"given":"Andrew","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly G.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Namazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nowak-Wegrzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.05.003_bib1","series-title":"Registries for evaluating patient outcomes: a user\u2019s guide","year":"2020"},{"key":"10.1016\/j.jaip.2024.05.003_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2019.02.025","article-title":"Harmonized outcome measures for use in asthma patient registries and clinical practice","volume":"144","author":"Gliklich","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib3","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/all.12475","article-title":"First European data from the network of severe allergic reactions (NORA)","volume":"69","author":"Worm","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.05.003_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaci.2014.08.025","article-title":"The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy","volume":"135","author":"Namazy","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s10875-014-0028-1","article-title":"USIDNET: a strategy to build a community of clinical immunologists","volume":"34","author":"Sullivan","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/ACI.0000000000000265","article-title":"Registries as useful tools in characterization of allergic manifestations","volume":"16","author":"Jares","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-7022-2-21","article-title":"Research needs in allergy: an EAACI position paper, in collaboration with EFA","volume":"2","author":"Papadopoulos","year":"2012","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2024.05.003_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaci.2015.02.003","article-title":"Incidence rates of atopic dermatitis, asthma, and allergic rhinoconjunctivitis in Danish and Swedish children","volume":"136","author":"Henriksen","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107429","article-title":"Real-life studies and registries of severe asthma: the advent of digital technology","volume":"220","author":"Urdova","year":"2023","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2024.05.003_bib12","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jama.2009.1092","article-title":"Registries for robust evidence","volume":"302","author":"Dreyer","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.05.003_bib13","first-page":"142","article-title":"Evaluation and implementation of public health registries","volume":"106","author":"Solomon","year":"1991","journal-title":"Public Health Rep"},{"key":"10.1016\/j.jaip.2024.05.003_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40271-023-00619-w","article-title":"So you want to build your disease\u2019s first online patient registry: an educational guide for patient organizations based on us and European experience","volume":"16","author":"Wicks","year":"2023","journal-title":"Patient"},{"key":"10.1016\/j.jaip.2024.05.003_bib15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10552-005-4501-2","article-title":"Cancer surveillance research: a vital subdiscipline of cancer epidemiology","volume":"16","author":"Glaser","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jaip.2024.05.003_bib16","doi-asserted-by":"crossref","DOI":"10.7717\/peerj-cs.1888","article-title":"exKidneyBERT: a language model for kidney transplant pathology reports and the crucial role of extended vocabularies","volume":"10","author":"Yang","year":"2024","journal-title":"PeerJ Comput Sci"},{"key":"10.1016\/j.jaip.2024.05.003_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12859-024-05693-x","article-title":"GPAD: a natural language processing-based application to extract the gene-disease association discovery information from OMIM","volume":"25","author":"Rahit","year":"2024","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaip.2024.05.003_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/19322968241228555","article-title":"Identifying diabetes related-complications in a real-world free-text electronic medical records in Hebrew using natural language processing techniques","author":"Saban","year":"2024","journal-title":"J\u00a0Diabetes Sci Technol."},{"key":"10.1016\/j.jaip.2024.05.003_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286669","article-title":"A\u00a0quality management system aiming to ensure regulatory-grade data quality in a glaucoma registry","volume":"18","author":"Wada","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2024.05.003_bib21","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.2196\/medinform.3937","article-title":"Balancing the interests of patient data protection and medication safety monitoring in a public-private partnership","volume":"3","author":"Dreyer","year":"2015","journal-title":"JMIR Med Inform"},{"key":"10.1016\/j.jaip.2024.05.003_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/00102200500446896","article-title":"Feasibility of a national fatal asthma registry: more evidence of IRB variation in evaluation of a standard protocol","volume":"43","author":"Clark","year":"2006","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2024.05.003_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease. Report on a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2024.05.003_bib24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/bioinformatics\/btl675","article-title":"The ESID online database network","volume":"23","author":"Guzman","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaip.2024.05.003_bib25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s10875-011-9594-7","article-title":"Nationwide survey of patients with primary immunodeficiency diseases in Japan","volume":"31","author":"Ishimura","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10875-007-9105-z","article-title":"Primary immunodeficiency diseases in Australia and New Zealand","volume":"27","author":"Kirkpatrick","year":"2007","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/A:1020660416865","article-title":"Primary immunodeficiency in Iran: first report of the National Registry of PID in Children and Adults","volume":"22","author":"Aghamohammadi","year":"2002","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<261::AID-HUMU1>3.0.CO;2-K","article-title":"Registries of immunodeficiency patients and mutations","volume":"10","author":"Lappalainen","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaip.2024.05.003_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/1744666X.2020.1801422","article-title":"Global systematic review of primary immunodeficiency registries","volume":"16","author":"Abolhassani","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1032358","article-title":"Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021","volume":"13","author":"Abolhassani","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib31","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jaip.2020.02.019","article-title":"Supplementation of the ESID registry working definitions for the clinical diagnosis of inborn errors of immunity with encoded human phenotype ontology (HPO) terms","volume":"8","author":"Gasteiger","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib32","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jaci.2018.12.1010","article-title":"Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT\/ESID-IEWP-SCETIDE-PIDTC study","volume":"143","author":"Ferrua","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib33","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2023.06.015","article-title":"Activated phosphoinositide 3-kinase \u03b4 syndrome: update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity","volume":"152","author":"Maccari","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib34","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1007\/s10875-021-01090-8","article-title":"Simple measurement of IgA predicts immunity and mortality in ataxia-telangiectasia","volume":"41","author":"Zielen","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109759","article-title":"Who\u2019s your data? Primary immune deficiency differential diagnosis prediction via machine learning and data mining of the USIDNET registry","volume":"255","author":"M\u00e9ndez Barrera","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib36","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s10875-020-00916-1","article-title":"Infection phenotypes among patients with primary antibody deficiency mined from a US patient registry","volume":"41","author":"Pickett","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib37","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jaip.2023.03.030","article-title":"Outcomes among racial and ethnic minority groups with X-linked agammaglobulinemia from the USIDNET registry","volume":"11","author":"O\u2019Toole","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib38","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jaip.2020.02.010","article-title":"Food allergy from infancy through adulthood","volume":"8","author":"Sicherer","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jaip.2022.10.006","article-title":"Prevalence and correlates of co-occurring allergies in a US food allergy patient registry","volume":"11","author":"Bilaver","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaip.2020.08.011","article-title":"Understanding food-related allergic reactions through a US national patient registry","volume":"9","author":"Fierstein","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaip.2023.09.021","article-title":"Food allergy symptoms in adults and children using the Food Allergy Research & Education Patient Registry","volume":"12","author":"McIntyre","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib42","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.jaip.2020.12.018","article-title":"Characteristics of food allergic reactions in United States restaurants","volume":"9","author":"Oriel","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaip.2021.09.041","article-title":"Restaurant takeout practices of food-allergic individuals and associated allergic reactions in the COVID-19 era","volume":"10","author":"Zhang","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib44","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jaip.2023.10.042","article-title":"Allergic reactions during travel among individuals with IgE-mediated food allergy","volume":"12","author":"Brady","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib45","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1016\/j.jaip.2021.05.009","article-title":"characterizing biphasic food-related allergic reactions through a US food allergy patient registry","volume":"9","author":"Gupta","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib46","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jaip.2023.02.008","article-title":"Food Allergy Characteristics associated with coexisting eosinophilic esophagitis in FARE registry participants","volume":"11","author":"Guarnieri","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib48","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.anai.2020.02.001","article-title":"Fatal food anaphylaxis: registering a rare outcome","volume":"124","author":"Dorris","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib49","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.anai.2018.06.011","article-title":"Oral immunotherapy for food allergy: the FAST perspective","volume":"121","author":"Wasserman","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.anai.2019.05.002","article-title":"Meeting Faculty. Reaching for best practices in food oral immunotherapy: report on the second annual Food Allergy Support Team meeting","volume":"123","author":"Wasserman","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib51","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1016\/j.jaip.2023.09.017","article-title":"Oral immunotherapy in US allergy practice","volume":"11","author":"Wasserman","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib52","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.jaip.2021.02.046","article-title":"An approach to the office-based practice of food oral immunotherapy","volume":"9","author":"Wasserman","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.iac.2005.11.002","article-title":"The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms","volume":"26","author":"Kwon","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.05.003_bib54","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.jaip.2020.01.016","article-title":"Perinatal outcomes associated with maternal asthma and its severity and control during pregnancy","volume":"8","author":"Yland","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaci.2019.05.019","article-title":"Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort","volume":"145","author":"Namazy","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib59","article-title":"Cutaneous toxicity associated with enfortumab vedotin: a real-word study leveraging U.S. food and drug administration adverse event reporting system","volume":"11","author":"Yang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaip.2024.05.003_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100951","article-title":"Stevens-Johnson syndrome\/toxic epidermal necrolysis in patients treated with immune checkpoint inhibitors: a safety analysis of clinical trials and FDA pharmacovigilance database","volume":"37","author":"Zhu","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaip.2024.05.003_bib61","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1248\/bpb.35.967","article-title":"Adverse event profile of tigecycline: data mining of the public version of the U.S. Food and Drug Administration adverse event reporting system","volume":"35","author":"Kadoyama","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jaip.2024.05.003_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1259628","article-title":"The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS database","volume":"14","author":"Yang","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2024.05.003_bib63","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s40264-013-0116-9","article-title":"Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database","volume":"36","author":"Brinker","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2024.05.003_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14273","article-title":"Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome\/toxic epidermal necrolysis: data mining the public version of the FDA adverse event reporting system","volume":"75","author":"Xu","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib65","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/epi.14591","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: an analysis of the US Food and Drug Administration Adverse Event Reporting System","volume":"59","author":"Borrelli","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaip.2024.05.003_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.896867","article-title":"Stevens-Johnson syndrome following non-steroidal anti-inflammatory drugs: a real-world analysis of post-marketing surveillance data","volume":"10","author":"Shao","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2024.05.003_bib67","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.alit.2015.01.002","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: the Food and Drug Administration adverse event reporting system, 2004-2013","volume":"64","author":"Abe","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2024.05.003_bib68","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.vaccine.2019.12.028","article-title":"Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017","volume":"38","author":"Su","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2024.05.003_bib69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00006454-200102000-00022","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system","volume":"20","author":"Ball","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaip.2024.05.003_bib72","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.anai.2023.07.024","article-title":"Drug allergy in older adults: a study from the United States Drug Allergy Registry","volume":"131","author":"Accarino","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib73","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jaci.2023.08.018","article-title":"United States Drug Allergy Registry (USDAR) grading scale for immediate drug reactions","volume":"152","author":"Khan","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib74","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1016\/j.jaip.2020.08.018","article-title":"Patient characteristics and concerns about drug allergy: a report from the United States Drug Allergy Registry","volume":"8","author":"Blumenthal","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib76","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaip.2019.06.009","article-title":"Multiple drug hypersensitivity syndrome in a large database","volume":"8","author":"Landry","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib77","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jaip.2019.04.014","article-title":"Large health system databases and drug hypersensitivity","volume":"7","author":"Chiriac","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib78","article-title":"Drug allergy profile from a national drug allergy registry","volume":"11","author":"Al-Ahmad","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2024.05.003_bib80","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1016\/j.jaip.2022.08.008","article-title":"Anaphylaxis after COVID-19 vaccination: a registry-based study","volume":"10","author":"Jaggers","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib81","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/all.15447","article-title":"Urticaria and\/or angioedema secondary to mRNA COVID-19 vaccines: updates from a United States case registry","volume":"78","author":"Anvari","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.05.003_bib82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdin.2022.03.017","article-title":"Delayed large local reactions to Moderna COVID-19 vaccine: a follow-up report after booster vaccination","volume":"8","author":"Blumenthal","year":"2022","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaip.2024.05.003_bib83","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMc2102131","article-title":"Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2","volume":"384","author":"Blumenthal","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.05.003_bib84","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jdin.2022.04.004","article-title":"Cutaneous reactions following booster dose administration of COVID-19 mRNA vaccine: a first look from the American Academy of Dermatology\/International League of Dermatologic Societies registry","volume":"8","author":"Prasad","year":"2022","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaip.2024.05.003_bib85","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/j.jaad.2021.11.016","article-title":"Skin reactions to COVID-19 vaccines: an American Academy of Dermatology\/International League of Dermatological Societies registry update on reaction location and COVID vaccine type","volume":"86","author":"Freeman","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2024.05.003_bib86","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaad.2021.09.002","article-title":"Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study","volume":"86","author":"McMahon","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2024.05.003_bib87","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1111\/jdv.17646","article-title":"Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry","volume":"36","author":"Fathy","year":"2022","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2024.05.003_bib88","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2024.05.003_bib90","doi-asserted-by":"crossref","first-page":"621","DOI":"10.15585\/mmwr.mm7223a2","article-title":"Safety monitoring of mRNA COVID-19 vaccine third doses among children aged 6 months-5 years\u2014United States, June 17, 2022-May 7, 2023","volume":"72","author":"Hause","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2024.05.003_bib91","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1016\/j.vaccine.2023.06.023","article-title":"Post-authorization safety surveillance of Ad.26.COV2.S vaccine: reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022","volume":"41","author":"Woo","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2024.05.003_bib92","first-page":"1536","article-title":"Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons","volume":"385","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.05.003_bib94","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2024.05.003_bib95","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0140-6736(98)05418-X","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions","volume":"353","author":"Rzany","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.05.003_bib96","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2024.05.003_bib97","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2024.05.003_bib98","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2024.05.003_bib99","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2024.05.003_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.832048","article-title":"Drug-induced severe cutaneous adverse reactions: insights into clinical presentation, immunopathogenesis, diagnostic methods, treatment, and pharmacogenomics","volume":"13","author":"Tempark","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2024.05.003_bib102","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055906","article-title":"Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)","volume":"12","author":"James","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2024.05.003_bib103","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4168\/aair.2019.11.2.241","article-title":"Severe cutaneous adverse reactions in Korean pediatric patients: a study from the Korea SCAR Registry","volume":"11","author":"Oh","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2024.05.003_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100738","article-title":"Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: a study from the Korea SCAR registry","volume":"16","author":"Kim","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2024.05.003_bib105","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4168\/aair.2019.11.5.709","article-title":"Severe cutaneous adverse reactions to antiepileptic drugs: a nationwide registry-based study in Korea","volume":"11","author":"Park","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2024.05.003_bib106","first-page":"73","article-title":"A\u00a010-years retrospective study on Severe Cutaneous Adverse Reactions (SCARs) in a tertiary hospital in Penang, Malaysia","volume":"73","author":"Loo","year":"2018","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.jaip.2024.05.003_bib107","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jama.2014.7859","article-title":"Genetic variants associated with phenytoin-related severe cutaneous adverse reactions","volume":"312","author":"Chung","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.05.003_bib108","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaci.2020.08.003","article-title":"Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians","volume":"147","author":"Wang","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib109","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/clpt.2013.55","article-title":"HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children","volume":"94","author":"Amstutz","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2024.05.003_bib110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","article-title":"SJS\/TEN 2017: building multidisciplinary networks to drive science and translation","volume":"6","author":"White","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib111","article-title":"Updates in SJS\/TEN: collaboration, innovation, and community","volume":"10","author":"Marks","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2024.05.003_bib112","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.02.003","article-title":"SJS\/TEN 2019: from science to translation","volume":"98","author":"Chang","year":"2020","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2024.05.003_bib113","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jaad.2023.05.067","article-title":"Drug reaction eosinophilia and systemic symptoms: clinical phenotypic patterns according to causative drug","volume":"90","author":"Blumenthal","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2024.05.003_bib114","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/jamadermatol.2022.3541","article-title":"Risk factors for vancomycin drug reaction with eosinophilia and systemic symptoms syndrome","volume":"158","author":"Blumenthal","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2024.05.003_bib115","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1016\/j.jaip.2023.08.009","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical presentation and outcomes in people of color","volume":"11","author":"Bassir","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib116","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.11124\/JBIES-21-00182","article-title":"Overview of registries for anaphylaxis: a scoping review","volume":"20","author":"Stiles","year":"2022","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.jaip.2024.05.003_bib117","doi-asserted-by":"crossref","first-page":"23","DOI":"10.18176\/jiaci.0515","article-title":"Anaphylaxis: a decade of a Nationwide Allergy Society Registry","volume":"32","author":"Gaspar","year":"2021","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib118","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/pai.13511","article-title":"Anaphylaxis in children and adolescents: the Portuguese Anaphylaxis Registry","volume":"32","author":"Gaspar","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2023.100748","article-title":"Latin American anaphylaxis registry","volume":"16","author":"Jares","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2024.05.003_bib121","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/all.15612","article-title":"Different phenotypes of drug-induced anaphylaxis-data from the European Anaphylaxis Registry","volume":"78","author":"Hanschmann","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.05.003_bib122","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40629-019-00109-2","article-title":"Drug-induced anaphylaxis\u2014elicitors, mechanisms and diagnosis","volume":"28","author":"Worm","year":"2019","journal-title":"Allergo J Int"},{"key":"10.1016\/j.jaip.2024.05.003_bib123","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1111\/jdv.17327","article-title":"Anaphylaxis to vaccination and polyethylene glycol: a perspective from the European Anaphylaxis Registry","volume":"35","author":"Kraft","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2024.05.003_bib124","doi-asserted-by":"crossref","DOI":"10.2196\/15588","article-title":"Benefits and disadvantages of electronic patient-reported outcome measures: systematic review","volume":"3","author":"Meirte","year":"2020","journal-title":"JMIR Perioper Med"},{"key":"10.1016\/j.jaip.2024.05.003_bib125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaip.2022.09.041","article-title":"Achieving racial representation in food allergy research: a modified Delphi study","volume":"11","author":"Bilaver","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib126","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jaci.2021.02.034","article-title":"Health disparities in allergic and immunologic conditions in racial and ethnic underserved populations: a Work Group Report of the AAAAI Committee on the Underserved","volume":"147","author":"Davis","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.05.003_bib127","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1016\/j.jaip.2021.03.021","article-title":"Clinical disparity of primary antibody deficiency patients at a safety net hospital","volume":"9","author":"Wallace","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib128","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.jaip.2021.04.025","article-title":"Ascertainment bias in anaphylaxis safety data of COVID-19 vaccines","volume":"9","author":"Hourihane","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.05.003_bib129","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/pds.4150","article-title":"A\u00a0systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selection","volume":"26","author":"Gelperin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaip.2024.05.003_bib130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40264-017-0591-5","article-title":"Enrollment and retention in 34 United States pregnancy registries contrasted with the manufacturer\u2019s capture of spontaneous reports for exposed pregnancies","volume":"41","author":"Bird","year":"2018","journal-title":"Drug Saf"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824004707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824004707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T09:45:40Z","timestamp":1728294340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824004707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":115,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2213219824004707"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.05.003","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving Clinical Practice Through Patient Registries in Allergy and Immunology","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}